GlassScriptPhysician profile
James M Paci
NPI 1316101447
$2,126,342.16
in general payments reported to CMS, 2019-2025
25 companies · $538K in 2025
The $538K reported for 2025 was more than what 99% of Sports Medicine (Orthopaedic Surgery) providers received nationally (typical 2025 total: $686).
See the full distribution for Sports Medicine (Orthopaedic Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109K · 2020: $104K · 2021: $166K · 2022: $321K · 2023: $399K · 2024: $489K · 2025: $538K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Royalty Or License: $1.3M · Consulting Fee: $57K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $53K · Travel and Lodging: $9,163 · Food and Beverage: $6,745.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Royalty Or License | $1,300,819.58 |
| Consulting Fee | $56,940.00 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $52,780.00 |
| Travel and Lodging | $9,162.81 |
| Food and Beverage | $6,745.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $2,093,890.02 | 2019-2025 | Arthrex |
| Djo, LLC | $10,522.12 | 2021-2025 | Donjoy, Procare, Cmf |
| Gotham Surgical Solutions & Devices, INC. | $4,729.34 | 2019-2021 | |
| Medacta USA, INC. | $4,145.40 | 2023-2024 | Mecta |
| Endo Pharmaceuticals INC. | $3,415.92 | 2020 | |
| Xiros INC | $1,750.00 | 2020 | |
| Miach Orthopaedics, INC. | $1,056.01 | 2022-2024 | |
| Smith+Nephew, INC. | $1,013.50 | 2019-2022 | |
| Arcuro Medical INC | $987.61 | 2024-2025 | Superball, Superball |
| Polaris Technology Solutions LLC | $721.59 | 2024-2025 | |
| Stryker Corporation | $686.32 | 2023-2025 | Triathlon, Mako, Accolade |
| Zimmer Biomet Holdings, INC. | $672.66 | 2019-2023 | Tricera Handpiece |
| Horizon Therapeutics Plc | $458.30 | 2019-2022 | |
| Bioventus LLC | $408.36 | 2023-2025 | Durolane, Agili-C, Xcell |
| Embody, INC. | $389.88 | 2021-2022 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Linvatec Corporation | $384.66 | 2022-2024 | Biobrace 23mm, Allograft Tissue |
| Lifenet Health | $360.63 | 2019-2021 | |
| Depuy Synthes Sales INC. | $172.59 | 2022 | |
| Cartiheal (2009) LTD. | $135.32 | 2023 | Agili-C |
| Suvon Surgical LLC | $124.79 | 2023 | |
| Cgg Medical INC | $110.22 | 2025 | |
| Medtronic, INC. | $81.17 | 2021 | |
| Abanza INC. | $61.36 | 2025 | Washercap Mini Fixation System 4.5mm, Washercap Fixation System 10mm |
| Stimwave Technologies Incorporated | $50.00 | 2019 | |
| Triad Life Sciences INC. | $14.39 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Paci listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.